There are 2789 resources available
Introduction by the chair
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Bispecific antibodies
Presenter: Roch Houot
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Webcast
Polling 2 (led by chair)
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
CAR T-cells
Presenter: Marcela Maus
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Q&A
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
No
Presenter: Christian Buske
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Q&A
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Yes
Presenter: Thomas Lister
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Lena Specht
Session: Follicular lymphoma: Is watch and wait still a valid option in 2021?
Resources:
Slides
Webcast